![Andrew Bishop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Bishop
Director of Finance/CFO at
ARCH BIOPARTNERS INC.
Net worth: 247 260 $ as of 31/05/2026
Profile
Andrew Bishop is Chief Financial Officer & Executive Director at Arch Biopartners, Inc. since 2010.
Mr. Bishop is Principal at Bingley Capital, Inc. since 2009.
Former roles include Independent Director at Liminal BioSciences, Inc., Director at Willow Breast & Hereditary Cancer Support, Director at AmacaThera, Inc., Principal at Gordon Capital Corp., Principal at HSBC Securities (Canada), Inc., and Principal at First Marathon Securities Ltd. Education includes undergraduate studies at McGill University and an MBA from The Schulich School of Business, conferred in 1993.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 04/11/2025 | 780,000 ( 1.15% ) | 247 260 $ | 31/05/2026 |
Andrew Bishop active positions
| Companies | Position | Start |
|---|---|---|
| ARCH BIOPARTNERS INC. | Director of Finance/CFO | 01/04/2010 |
Bingley Capital, Inc.
 Bingley Capital, Inc. Investment ManagersFinance Bingley Capital invests in small and medium scale companies with EBITDA of at least $2 million and sales of $10 to $100 million. The firm targets companies in the fields of industrial and Consumer Products. They do not invest in retailing, real estate, mining, oil & gas and technology-based companies. Bingley acquires controlling interests and provides financing in the form of equity & debt for buyout, MBO and growth capital requirements. | Private Equity Investor | 01/01/2009 |
Former positions of Andrew Bishop
| Companies | Position | End |
|---|---|---|
AmacaThera, Inc.
 AmacaThera, Inc. Medical SpecialtiesHealth Technology Engages in developing and commercializing of injectable hydrogel platform technology for a wide range of medical applications | Director/Board Member | - |
Willow Breast & Hereditary Cancer Support | Chairman | - |
Gordon Capital Corp.
 Gordon Capital Corp. Investment Banks/BrokersFinance Provides investing banking services | Corporate Officer/Principal | - |
HSBC Securities (Canada), Inc.
 HSBC Securities (Canada), Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
First Marathon Securities Ltd.
 First Marathon Securities Ltd. Investment Banks/BrokersFinance Provides security brokerage and flotation services | Corporate Officer/Principal | - |
Training of Andrew Bishop
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
22
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Gordon Capital Corp.
Gordon Capital Corp. Investment Banks/BrokersFinance Provides investing banking services | Finance |
HSBC Securities (Canada), Inc.
HSBC Securities (Canada), Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
First Marathon Securities Ltd.
First Marathon Securities Ltd. Investment Banks/BrokersFinance Provides security brokerage and flotation services | Finance |
Arch Biopartners, Inc.
 Arch Biopartners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops novel drugs | Health Technology |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bingley Capital, Inc.
Bingley Capital, Inc. Investment ManagersFinance Bingley Capital invests in small and medium scale companies with EBITDA of at least $2 million and sales of $10 to $100 million. The firm targets companies in the fields of industrial and Consumer Products. They do not invest in retailing, real estate, mining, oil & gas and technology-based companies. Bingley acquires controlling interests and provides financing in the form of equity & debt for buyout, MBO and growth capital requirements. | Finance |
Willow Breast & Hereditary Cancer Support | |
AmacaThera, Inc.
AmacaThera, Inc. Medical SpecialtiesHealth Technology Engages in developing and commercializing of injectable hydrogel platform technology for a wide range of medical applications | Health Technology |
- Stock Market
- Insiders
- Andrew Bishop
